Featured Articles in thrombosis journals

Featured Articles in thrombosis journals 2022-11-16

Featured Articles inthrombosis journals

Thrombosis and Haemostasis

IF 2021: 6.830

Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper

Diana A. Gorog, Ying X. Gue, Tze-Fan Chao, Laurent Fauchier, Jose Luis Ferreiro et al.

While there is a clear clinical benefit of oral anticoagulation in patients with atrial fibrillation (AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major bleeding events (especially intracranial bleeds) may still occur and be devastating.

TH Open

Thrombosis and Haemostasis的开放获取姊妹期刊

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome

Tess Van Meerhaeghe, Alexandre Cez, Karine Dahan, Emmanuel Esteve, Ismail Elalamy, Jean Jacques Boffa, Eleonore Ponlot

Nephrotic syndrome (NS) is associated with an increased risk of thromboembolic events (TEs), due to hemostatic derangements. The use of direct oral anticoagulants (DOACs) in the prevention of TE has not been studied intensively in patients suffering from NS.

Seminars in Thrombosis and Hemostasis

IF 2021: 6.398

Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians

Hanny Al-Samkari

This review article and practical evidence-based guide aim to fill this unaddressed need, synthesizing published data on the use of antiangiogenic agents in HHT, relevant data for their use outside of HHT, and expert guidance where evidence is lacking.

Hämostaseologie

IF 2021: 2.145

Platelet Dysregulation in the Pathobiology of COVID-19

Rebecca A. Mellema , Jacob Crandell , Aaron C. Petrey

This review summarizes the current knowledge of platelet alterations observed in the context of COVID-19 and their impact upon disease pathobiology.

上一篇：David W. C. MacMillan：2021年诺贝尔化学奖获得者下一篇：氨甲环酸在脊柱融合手术中全身和局部同时应用的疗效返回列表